CD103+ tissue-resident T-cells in head and neck squamous cell carcinomas of patients treated anti-PD-1 therapy.
Cancer treatment and research communications
View this publicationCancer treatment and research communications
View this publicationCancers
View this publicationAktuelle Urologie
View this publicationNature communications
View this publicationBMC cancer
View this publicationJCI insight
View this publicationAngewandte Chemie (International ed. in English)
View this publication